Market Research Logo

Global Cell Therapy Market 2017-2021

Global Cell Therapy Market 2017-2021

About Cell Therapy

Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.

Technavio’s analysts forecast the global cell therapy market to grow at a CAGR of 23.27% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cell therapy market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Dendreon
  • Mesoblast
  • Vericel
Other prominent vendors
  • AlloCure
  • Amorcyte
  • Anterogen
  • Antibe Therapeutics
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • AxoGen
  • Bellicum Pharmaceuticals
  • BioCardia
  • BIOCELLULAR THERAPIES
  • Biogen Idec
  • Bio-Tissue
  • BIOTIME
  • BioTissue Technologies
  • BrainStorm Cell Therapeutics
  • Bluebird Bio
  • Bone Therapeutics
  • Caladrius
  • Capricor Therapeutics
  • CellBioMed
  • Celgene
  • Cell Medica
  • CellPraxis
  • CellSeed
  • Cell Therapy
  • Celyad
  • CESCA THERAPEUTICS
  • CRC for Cell Therapy Manufacturing
  • CryoLife
  • Cynata Therapeutics
  • Cytori Therapeutics
  • DiscGenics
  • Fate Therapeutics
  • Fibrocell Science
  • Forticell Bioscience
  • Fortress Biotech
  • Gamida Cell
  • GlaxoSmithKline
  • Healthpoint
  • Histogen
  • Histogenics
  • Holostem Terapie Avanzate
  • Humacyte
  • Immunocellular Therapeutics
  • Integra Life Sciences
  • Intercytex
  • iSTO Technologies
  • Janssen Pharma
  • Juno Therapeutics
  • Juventas Therapeutics
  • Kensey Nash
  • Kite Pharma
  • Kiadis Pharma
  • LifeNet Health
  • Living Cell Technologies
  • Lonza
  • MaxCyte
  • MEDIPOST
  • Nanofiber Solutions
  • Nanotope
  • Neuralstem
  • Newlink Genetics
  • Northwest Biotherapeutics
  • NovaRx
  • Ocata Therapeutics
  • Opexa Therapeutics
  • Orbsen Therapeutics
  • Pfizer
  • Pharmicell
  • Pluristem Therapeutics
  • Prima BioMed
  • Q Therapeutics
  • Regenerexx
  • Regeneus
  • Regenerys
  • Regience
  • Regrow
  • RepliCel
  • ReproCELL
  • ReNeuron
  • RenovaCare
  • RESSTORE
  • RhinoCyte
  • Rohto Pharmaceutical
  • SanBio
  • Sangamo BioSciences
  • Shanghai Sunway Biotech
  • Shire Regenerative Medicine
  • StemCells
  • STEMPEUTICS RESEARCH
  • Synergistic Technologies
  • t2cure
  • Takara Bio
  • tella
  • Tengion
  • TissueGene
  • Tessa Therapeutics
  • Txcell
  • VentriNova
  • ViaCyte
  • VistaGen Therapeutics
  • SDRMI and Xcelthera
Market driver
  • Increase in prevalence of chronic diseases
  • For a full, detailed list, view our report
Market challenge
  • High cost of clinical trials and cell therapy doses
  • For a full, detailed list, view our report
Market trend
  • Proliferation of strategic alliances and royalty payments
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Cell Therapy Market 2017-2021

Technavio recognizes the following companies as the key players in the global cell therapy market: Dendreon, Mesoblast, and Vericel.

Other Prominent Vendors in the market are: AlloCure, Amorcyte, Anterogen, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bellicum Pharmaceuticals, BioCardia, BIOCELLULAR THERAPIES, Biogen Idec, Bio-Tissue, BIOTIME, BioTissue Technologies, BrainStorm Cell Therapeutics, Bluebird Bio, Bone Therapeutics, Caladrius, Capricor Therapeutics, CellBioMed, Celgene, Cell Medica, CellPraxis, CellSeed, Cell Therapy, Celyad, CESCA THERAPEUTICS, CRC for Cell Therapy Manufacturing, CryoLife, Cynata Therapeutics, Cytori Therapeutics, DiscGenics, Fate Therapeutics, Fibrocell Science, Forticell Bioscience, Fortress Biotech, Gamida Cell, GlaxoSmithKline, Healthpoint, Histogen, Histogenics, Holostem Terapie Avanzate, Humacyte, Immunocellular Therapeutics, Integra Life Sciences, Intercytex, iSTO Technologies, Janssen Pharma, Juno Therapeutics, Juventas Therapeutics, Kensey Nash, Kite Pharma, Kiadis Pharma, LifeNet Health, Living Cell Technologies, Lonza, MaxCyte, MEDIPOST, Nanofiber Solutions, Nanotope, Neuralstem, Newlink Genetics, Northwest Biotherapeutics, NovaRx, Ocata Therapeutics, Opexa Therapeutics, Orbsen Therapeutics, Pfizer, Pharmicell, Pluristem Therapeutics, Prima BioMed, Q Therapeutics, Regenerexx, Regeneus, Regenerys, Regience, Regrow, RepliCel, ReproCELL, ReNeuron, RenovaCare, RESSTORE, RhinoCyte, Rohto Pharmaceutical, SanBio, Sangamo BioSciences, Shanghai Sunway Biotechm, Shire Regenerative Medicine, StemCells, STEMPEUTICS RESEARCH, Synergistic Technologies, t2cure, Takara Bio, Tella, Tengion, TissueGene, Tessa Therapeutics, Txcell, VentriNova, ViaCyte, VistaGen Therapeutics, and SDRMI and Xcelthera.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Proliferation of strategic alliances and royalty payments. Strategic alliances have affected the growth of the market in emerging regions such as APAC. Several vendors prefer M&A to strengthen their global position and improve their commercial capabilities. Through strategic alliances, many companies are receiving upfront and royalty payments, which they use for R&D to develop novel regenerative medicine products.”

According to the report, one of the major drivers for this market is Increase in prevalence of chronic diseases. The prevalence of chronic diseases such as diabetes and CVDs is growing. Diabetes causes diabetic retinopathy and diabetic foot ulcer. CVDs such as coronary heart disease (CHD) can cause stroke. The increase in prevalence of chronic diseases increases the cost burden on healthcare systems. For instance, according to the CDC, in February 2010, stroke and heart disease cost the Government of the US around $315.4 billion. Cell therapy products can treat such diseases and reduce the economic burden on healthcare systems.

Further, the report states that one of the major factors hindering the growth of this market is High cost of clinical trials and cell therapy doses. The cost of clinical trials and product launches can increase the cost burden on manufacturers. Most companies that offer cell therapy products are small. Such companies require government or private funding. However, most organizations provide limited funding only if the target goal is achieved.

Companies Mentioned

Dendreon, Mesoblast, Vericel, AlloCure, Amorcyte, Anterogen, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bellicum Pharmaceuticals, BioCardia, BIOCELLULAR THERAPIES, Biogen Idec, Bio-Tissue, BIOTIME, BioTissue Technologies, BrainStorm Cell Therapeutics, Bluebird Bio, Bone Therapeutics, Caladrius, Capricor Therapeutics, CellBioMed, Celgene, Cell Medica, CellPraxis, CellSeed, Cell Therapy, Celyad, CESCA THERAPEUTICS, CRC for Cell Therapy Manufacturing, CryoLife, Cynata Therapeutics, Cytori Therapeutics, DiscGenics, Fate Therapeutics, Fibrocell Science, Forticell Bioscience, Fortress Biotech, Gamida Cell, GlaxoSmithKline, Healthpoint, Histogen, Histogenics, Holostem Terapie Avanzate, Humacyte, Immunocellular Therapeutics, Integra Life Sciences, Intercytex, iSTO Technologies, Janssen Pharma, Juno Therapeutics, Juventas Therapeutics, Kensey Nash, Kite Pharma, Kiadis Pharma, LifeNet Health, Living Cell Technologies, Lonza, MaxCyte, MEDIPOST, Nanofiber Solutions, Nanotope, Neuralstem, Newlink Genetics, Northwest Biotherapeutics, NovaRx, Ocata Therapeutics, Opexa Therapeutics, Orbsen Therapeutics, Pfizer, Pharmicell, Pluristem Therapeutics, Prima BioMed, Q Therapeutics, Regenerexx, Regeneus, Regenerys, Regience, Regrow, RepliCel, ReproCELL, ReNeuron, RenovaCare, RESSTORE, RhinoCyte, Rohto Pharmaceutical, SanBio, Sangamo BioSciences, Shanghai Sunway Biotechm, Shire Regenerative Medicine, StemCells, STEMPEUTICS RESEARCH, Synergistic Technologies, t2cure, Takara Bio, Tella, Tengion, TissueGene, Tessa Therapeutics, Txcell, VentriNova, ViaCyte, VistaGen Therapeutics, and SDRMI and Xcelthera.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Overview
      • Table Types of stem cells used in cell therapy products: Overview
    • Government funding and support
      • Table Collaborative funding for cell therapy-based research in US
  • Market landscape
    • Overview
      • Table Ethical challenges associated with stem cell research
      • Table Stem cell research policies in countries in Americas
      • Table Stem cell research policies in countries in EMEA
      • Table Stem cell research policies in countries in APAC
    • Market size and forecast
      • Table Global cell therapy market 2016-2021 ($ billions)
      • Table Global cell therapy market: Overview
  • Pipeline portfolio
    • Overview
    • Regulatory framework for cell therapy products
    • Pipeline analysis
      • Table Cell therapy pipeline for CVDs
      • Table Cell therapy pipelines for CNS, orthopedic, and ocular disorders
      • Table Cell therapy pipeline for dermatology and diabetes
      • Table Cell therapy pipeline for oncology
    • Five forces analysis
      • Table Five forces analysis
  • Segmentation by application
    • Overview
      • Table Global stem cell therapy market: Segmentation by application 2016 (% share)
    • Dermatology
      • Table Cell therapy for dermatology: Overview
      • Table Cell therapy for burns and diabetic wound treatment: Opportunity analysis
      • Table Cell therapy products for dermatology pipeline
    • Musculoskeletal
      • Table Cell therapy for musculoskeletal: Overview
      • Table Cell therapy for occupational and sports-related injuries: Overview
      • Table Cell therapy for musculoskeletal pipeline
    • Ocular
      • Table Cell therapy for ocular: Overview
      • Table Cell therapy for ocular pipeline
    • Cardiovascular
      • Table Cell therapy for cardiovascular: Overview
      • Table Cell therapy for cardiovascular: Overview
  • Segmentation by end-user
    • Table Global cell therapy market: Overview of segmentation by end-user
    • Hospitals and clinics
      • Table Funding and partnership for cell therapy product development
      • Table Hospital collaborations for cell therapy
    • ASCs
    • Regenerative medicine centers
  • Segmentation by geography
    • Overview
      • Table Global cell therapy market: Segmentation by geography 2016 and 2021 ($ billions)
    • Americas
      • Table Cell therapy market in Americas: Overview
      • Table Cell therapy market in Americas 2016-2021 ($ billions)
      • Table Cell therapy market in Americas: Overview by country
      • Table SBIR and STTR programs
      • Table Cell therapy market in US: Overview
    • EMEA
      • Table Cell therapy market in EMEA: Overview
      • Table Cell therapy market in EMEA 2016-2021 ($ billions)
      • Table Cell therapy market in EMEA: Overview by country
      • Table Cell therapy market in UK
    • APAC
      • Table Cell therapy market in APAC 2016-2021 ($ billions)
      • Table Cell therapy market in APAC: Overview by country
      • Table Cell therapy market in Japan: Overview
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Chronic diseases in US and Europe
      • Table Fall and hip fracture in US 2016
      • Table Number of road injuries in UK 2015
    • Market challenges
      • Table Regulatory challenges associated with regenerative medicine
  • Market trends
    • Focus on business strategies
      • Table Key business strategies adopted by companies
    • Proliferation of strategic alliances and royalty payments
      • Table Major strategic alliances
    • Geographic expansion of gene therapy
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis
      • Table Competitive landscape
      • Table Strategies for companies
      • Table Key recommendations for new entrants
  • Key vendor analysis
    • Dendreon
      • Table Dendreon: Key highlights
      • Table Dendreon: Strength assessment
      • Table Dendreon: Strategy assessment
      • Table Dendreon: Opportunity assessment
    • Mesoblast
      • Table Mesoblast: Key highlights
      • Table Mesoblast: Strength assessment
      • Table Mesoblast: Strategy assessment
      • Table Mesoblast: Opportunity assessment
    • Vericel
      • Table Vericel: Key highlights
      • Table Vericel: Strength assessment
      • Table Vericel: Strategy assessment
      • Table Vericel: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report